Insiders Arvinas, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
32.48 ^USD	+2.23%		-0.18%	-21.09%

Apr. 24	Arvinas, Inc. Appoints Randy Teel as Chief Business Officer	CI
Apr. 15	H.C. Wainwright Cuts Price Target on Arvinas to $87 From $90, Maintains Buy Rating	MT

Arvinas, Inc. Appoints Randy Teel as Chief Business Officer	Apr. 24	CI
Arvinas Appoints Noah Berkowitz as Chief Medical Officer	Mar. 18	MT
Arvinas, Inc. Appoints Noah Berkowitz as Chief Medical Officer and A Member of the Executive Committee	Mar. 18	CI
Arvinas, Inc. Announces Executive Changes, Effective February 29, 2024	Feb. 20	CI
Arvinas, Inc. Announces Appointment of Jared Freedberg as General Counsel	Jan. 16	CI
Arvinas Names John Houston Chairperson, Effective Thursday	23-06-15	MT
Arvinas, Inc. Announces Changes to its Board of Directors	23-06-15	CI
Arvinas, Inc. Appoints Kelly Page as Senior Vice President, Global Head of Oncology Strategy and Program Leadership	23-04-03	CI
Arvinas, Inc. Announces Executive Changes	22-12-16	CI
Arvinas Announces Changes to Its Board of Directors	22-12-16	CI
Brand Institute Partners on Nonproprietary Name for Novel Protein Degrader Under Development by Arvinas, Inc	22-12-05	CI
Arvinas, Inc. Appoints Paul McInulty as Senior Vice President, Regulatory Affairs	22-10-03	CI
Arvinas, Inc. Announces Changes to its Board of Directors	22-08-18	CI
Arvinas, Inc. Appoints Lisa Sinclair as Senior Vice President, Corporate Operations	22-08-15	CI
Arvinas, Inc. Appoints John Northcott as Chief Commercial Officer	22-08-01	CI
Insider Sell: Arvinas	22-04-19	MT
Insider Sell: Arvinas	22-03-16	MT
Insider Sell: Arvinas	22-02-18	MT
Insider Sell: Arvinas	22-01-20	MT
Insider Sell: Arvinas	21-12-17	MT

No results for this search